FEATURES OF THE SECOND TRIMESTER OF PREGNANCY IN WOMEN WITH A HISTORY OF ANTENATAL FETAL DEATH UNDER A PROPOSED THERAPEUTIC COMPLEX
DOI:
https://doi.org/10.11603/24116-4944.2025.2.15361Keywords:
pregnancy, antenatal fetal death, perinatal outcomes, endothelial dysfunction, Doppler sonography, estradiol, progesterone, prolactinAbstract
The aim of the study – to determine the clinical course and outcomes of the second trimester in pregnancies with a history of antenatal fetal death (AFD) under an individualized therapeutic and preventive approach. The study also aimed to evaluate the effectiveness of differentiated interventions based on presumed etiological factors.
Materials and Methods. A prospective study was carried out between 2021 and 2024 involving 146 women, of whom 84 had a history of AFD. These were divided into three subgroups: A – coagulation disorders; B – infectious background; C – unknown etiology. A control group included 30 low-risk pregnancies. All participants received tailored preconception and gestational care, including progesterone support, vitamin supplementation, endocrine and immune corrections, anticoagulants in group A, antimicrobial therapy in group B, and phytotherapeutic agents in group C. Evaluations included hormonal profiles (estriol, progesterone, placental lactogen), glucose tolerance testing, uterine artery Doppler indices, and transvaginal measurement of cervical length at 18–22 weeks of gestation.
Results and Discussion. The individualized approach yielded reduced complication rates in all main subgroups. Group A showed improved outcomes despite existing hemostatic dysfunctions, with decreased rates of miscarriage threat (from 38.7 % in the first to 9.7 % in the second trimester, p<0.05). In group B, complications were dominated by infections, contributing to increased preterm labor risk. Group C showed combined endocrine, infectious, and immunologic abnormalities. Progesterone levels increased significantly across all subgroups (by 39.1 %, 43.9 %, and 49.5 %, respectively), confirming treatment effectiveness. However, estriol and placental lactogen remained statistically lower than in controls, indicating ongoing placental insufficiency and elevated preterm risk. Doppler indices showed moderate S/D ratio elevation in group C, while resistance index remained within normal limits, reflecting vascular compensation. Cervical shortening was observed in group C (mean (35.4±0.7) mm), suggesting the need to continue hormonal support into the third trimester. Glucose tolerance testing revealed gestational diabetes in 34.1 % of women in group C, compared to 16.1 % in group A and only 3.3 % in the control group. This underscores impaired carbohydrate metabolism as a critical contributor to adverse outcomes in unexplained AFD cases.
Conclusions. The proposed tailored approach proved effective in enhancing hormonal balance, optimizing placental function, and reducing pregnancy complications during the second trimester. Group A demonstrated the highest response to therapy. For subgroup C, where AFD etiology remains unclear, extended multidisciplinary follow-up and intensified surveillance are necessary. The findings support the relevance of a personalized pregnancy management strategy in high-risk obstetric populations.
References
World Health Organization. Maternal and perinatal health profile: global and regional estimates. Geneva: WHO; 2022. 45 p.
Benyuk, V.O., Chebotariova, A.S., & Hichka, N.M. (2021). Osoblyvosti porushen i metody korektsii systemy hemostazu u zhinok z antenatalnoiu zahybelliu ploda [Features of hemostasis disorders and their correction in women with antenatal fetal death]. Reproduktyvne zdorovia zhinky, 3, 47-51. [in Ukrainian].
Hromova, A.V., Liakhovska, T.A., Siatina, Ye.Yu., & Mitiunina, N.V. (2019). Morphofunktsionalni osoblyvosti platsenty pry antenatalnii zahybeli ploda [Morphofunctional features of the placenta in antenatal fetal death]. Neonatol Khir Perinat Med., 9(3), 101-105. [in Ukrainian] DOI: https://doi.org/10.24061/2413-4260.IX.3.33.2019.6
Markin, L.B., & Fartushok, T.V. (2019). Profilaktyka porushen vaskuliaryzatsii platsenty u vahitnykh z vysokym ryzykom [Prevention of placental vascularization disorders in high-risk pregnancies]. Pediatriia, akusherstvo ta hinekolohiia, 2, 38-42. [in Ukrainian].
Chaiworapongsa, T., Romero, R., Erez, O. et al. (2017) The prediction of fetal death with a simple maternal blood test at 20–24 weeks: PlGF/sVEGFR-1 ratio. Am J Obstet Gynecol., 217(6). 682.e1–13. DOI: https://doi.org/10.1016/j.ajog.2017.10.001
Mozgovaya, E.V., Khodzhaeva, Z.S., & Pak, L.A. (2024). Thrombodynamics in preeclampsia risk assessment. J Obstet Womens Dis., 73(1), 40-45.
Thrombosis in pregnancy: maternal and fetal issues (1999). Lancet, 353(9160), 1258-1265. DOI: https://doi.org/10.1016/S0140-6736(98)10265-9
Fishel Bartal, M., & Sibai, B.M. (2022). Proteinuria during pregnancy: definition, pathophysiology, and clinical significance. Am J Obstet Gynecol., 226(2S), S960-S969. DOI: https://doi.org/10.1016/j.ajog.2020.08.108
Feng, X., Zhang, L., Zhang, Y. et al. (2021). Endothelial dysfunction in gestational hypertension: role of oxidative stress and inflammation. Drug Discov Today, 26(6), 1420-1426. DOI: https://doi.org/10.1016/j.drudis.2021.03.001
Benyuk, V.O., Maidannyk, I.V., & Ropotan, A.H. (2016). Dopplerometriia matkovykh arteriĭ u zhinok z vysokym perynatalnym ryzykom [Uterine artery Doppler in women with high perinatal risk]. Perinatol i Pediatriia, 2(66), 86-88 [in Ukrainian].
Plotkin, D. et al. (2020). Systematic review of Doppler for detecting perinatal mortality in low- and middle-income countries. Int J Gynecol Obstet., 149, 105-112.
Neilson, J.P., Alfirevic, Z., Gates, S. et al. (2010). Umbilical artery Doppler studies in high-risk pregnancies. Cochrane Database Syst Rev., 1, CD000073. DOI: https://doi.org/10.1002/14651858.CD000073.pub2
Deinichenko, O.V., Smolska, O.I., & Yakymovych, T.I. (2020). Hormonanyi profіl i krovotok u vahitnykh iz preeklampsiieiu [Hormonal profile and blood flow in pregnant women with preeclampsia]. Reproduktyvne zdorovia zhinky, 6, 53-56 [in Ukrainian].
Lockwood, C.J., Krikun, G., Schatz, F., et al. (1991). Amniotic fluid contains tissue factor: a potential link between the procoagulant and cytokine response in preterm parturition and amniotic fluid embolism. Am J Obstet Gynecol., 165(5). 1331-1338. DOI: https://doi.org/10.1016/S0002-9378(12)90756-5
Shchurko, D.M., Grygorieva, N.V., & Serdiuk, S.O. (2022). Features of the hemostasis system and fetoplacental complex in women with congenital fetal malformations. Reproductive Endocrinology, 63, 64, 53-58. DOI: https://doi.org/10.18370/2309-4117.2022.63.53-58
Ministry of Health of Ukraine (2022). Standarty medychnoyi dopomohy «Normalʹna vahitnistʹ»: nakaz vid 9 serpnya 2022 roku № 1437 [“Standards of medical care: Normal pregnancy” Order No. 1437 dated August 9, 2022] [in Ukrainian].
Papageorghiou, A.T., Ohuma, E.O., Altman, D.G., Todros, T. (2014). International standards for fetal growth based on serial ultrasound measurements: the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project. Lancet, 384(9946), 869-879. DOI: https://doi.org/10.1016/S0140-6736(14)61490-2
Tian Y., & Yang X. (2022). The role of uterine artery Doppler in pregnancy complications: current insights. Front Med., 9, 835642. DOI: https://doi.org/10.3389/fmed.2022.813343
Phoswa, W.N., & Khaliq, O.P. (2021). Oxidative stress and preeclampsia: pathophysiological and molecular mechanisms. Oxid Med Cell Longev, 2021, 5581570.
Jonard, M., Ducloy-Bouthors, A.S., & Fourrier, F. (2016). Comparison of DIC scores in pregnant ICU patients. PLoS One, 11(3), e0151571. DOI: https://doi.org/10.1371/journal.pone.0166471
Babienko V.V., Mokienko A.V., Levkovska V.Yu. (2022). Biostatystyka [Biostatistics]. Teaching manual, 124-157 [in Ukrainian].
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 В. О. Бенюк, Н. М. Гичка, І. В. Майданник, О. О. Чорна, О. А. Диндар, Т. Р. Никонюк, С. В. Бенюк
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in this journal agree to the following terms:
1. The authors reserve the right to authorship of the work and pass the journal right of first publication of this work is licensed under a Creative Commons Attribution License, which allows others to freely distribute the work published with reference to the authors of the original work and the first publication of this magazine.
2. Authors are entitled to enter into a separate agreement on additional non-exclusive distribution of work in the form in which it was published in the magazine (eg work place in the electronic repository institution or publish monographs in part), provided that the reference to the first publication of this magazine.
3. Policy magazine allows and encourages authors placement on the Internet (eg, in storage facilities or on personal websites) manuscript of how to submit the manuscript to the editor and during his editorial processing, since it contributes to productive scientific discussion and positive impact on the efficiency and dynamics of citing published work (see. The Effect of Open Access).
Accepted 2025-12-30
Published 2025-12-15
